|
|
Tahiti by Marty L. Hinz, MD of Cape Coral, FL
|
37.5 Hours of On-line |
Continuing Medical
Education
|
|
Management of The Effects of Neurotoxins |
|
on
Neurotransmission |
| |
|
Course Faculty |
|
|
| |
|
Marty
Hinz, MD |
|
Family
Practice / Emergency Medicine |
|
Morgan
Park Clinic |
|
Duluth,
MN |
| |
|
Since
the year 2000 Dr. Hinz has presented
over 2,000 hours of AMA PRA credit on the topic of
neurotransmitter dysfunction and
management |
| |
|
|
|
| |
|
Alvin
Stein, MD |
|
Orthopedic Surgeon |
|
Stein
Orthopedic Associates |
|
Plantation, FL |
| |
|
Dr.
Stein has presented numerous AMA PRA
credit at conferences
around the United State since 2007
on the topic of identification and
management of neurotoxins. |
| |
|
|
|
A Formidable Team |
|
Formidable Knowledge |
|
These two
faculty members have over 90 years of
combined experience in medicine. |
|
|
As produced in Johns Hopkins Medical
School peer reviewed writings, in
2009 Dr. Hinz published the "Bundle
Damage Theory" of neurotransmitter
dysfunction. The "Bundle Damage
Theory" is the first theory in over
60 years to move beyond the
"Monoamine Theory" in treatment of
neurotransmitter disease. Under the
bundle damage theory the leading
cause of chronic neurotransmitter
related disease is due to insult
from neurotoxins. |
|
|
Dr. Stein brings the the research
expertise of 15 years in the area of
identification and management of
neurotoxins in the clinic
environment. |
|
|
These two speakers have integrated
their areas of expertise into this
comprehensive medical program
integrating the identification and
management of neurotoxins with
treatment of residual permanent
neurotransmitter related disease
symptoms that are induced by
neurotoxins and other sources of
neuronal insult. |
|
|
This program is not about the rare
patient that may be seen once or
twice in a medical career. Patients
with monoamine neurotransmitter
disease induced by neurotoxic
neuronal insult are seen every day
in every practice. It is the goal of
this program to educate and open the
eyes of physicians so that these
patients are identified and started
on a course of treatment that is
effective. |
|
|
| |
| Peer
Reviewed Literature of The Faculty |
| based on
the research of Dr. Hinz and Dr. Stein. |
| |
|
|
| |
|
Disclosures: |
|
Dr. Marty Hinz has indicated he is the
Director of Clinical Research with
intellectual property rights to
NeuroResearch Clinics, Inc |
|
Dr. Alvin Stein has indicated he has no
relevant financial relationships to disclose
in regard to the content of his
presentations. |
|
| |
|
